Innate Pharma S.A. (LON:0EVI)

Innate Pharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	152	183	234	295	245	397
Market Cap Growth	-35.28%	-21.67%	-20.77%	20.59%	-38.25%	-7.09%
Enterprise Value	106	141	163	209	129	261
Last Close Price	1.81	2.22	2.96	3.66	3.11	5.04
PS Ratio	4.49	3.43	4.57	14.24	3.92	5.48
PB Ratio	5.27	4.07	4.87	3.27	1.75	2.15
P/TBV Ratio	5.29	4.10	5.02	5.56	2.49	3.89
P/FCF Ratio	-	-	-	-	-	13.91
P/OCF Ratio	-	-	-	-	-	13.40
EV/Sales Ratio	3.79	2.64	3.19	10.07	2.07	3.61
EV/EBITDA Ratio	-	-	-	-	10.86	17.87
EV/EBIT Ratio	-	-	-	-	133.87	195.73
EV/FCF Ratio	-6.80	-	-	-	-	9.16
Debt / Equity Ratio	1.23	0.77	0.78	0.41	0.12	0.09
Debt / EBITDA Ratio	-	-	-	-	1.33	1.03
Debt / FCF Ratio	-	-	-	-	-	0.56
Asset Turnover	0.19	0.31	0.24	0.09	0.20	0.20
Quick Ratio	2.76	3.51	3.21	1.67	3.64	1.90
Current Ratio	2.92	3.73	3.38	1.73	3.81	1.95
Return on Equity (ROE)	-78.59%	-14.28%	-71.75%	-34.53%	-0.44%	4.09%
Return on Assets (ROA)	-13.76%	-4.04%	-4.32%	-10.40%	0.19%	0.23%
Return on Capital (ROIC)	-29.62%	-8.41%	-8.28%	-18.30%	0.33%	0.48%
Return on Capital Employed (ROCE)	-	-	-	-	0.41%	0.56%
Earnings Yield	-18.94%	-3.58%	-22.02%	-15.02%	-23.41%	-4.43%
FCF Yield	-10.22%	-15.58%	-7.46%	-16.89%	-19.27%	7.19%
Buyback Yield / Dilution	-1.01%	-1.02%	-0.12%	-0.77%	-17.97%	-13.83%
Total Shareholder Return	-1.01%	-1.02%	-0.12%	-0.77%	-17.97%	-13.83%

Source: S&P Capital IQ. Standard template. Financial Sources.